Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
2018 | Genoptix, Inc. cancelled the acquisition of Rosetta Genomics Ltd.. | CI |
2018 | Rosetta Genomics Ltd.(NasdaqCM:ROSG) dropped from NASDAQ Composite Index | CI |
Sales 2015 | 8.27M 658M | Sales 2016 | 9.23M 735M | Capitalization | 9.22M 734M |
---|---|---|---|---|---|
Net income 2015 | -17M -1.35B | Net income 2016 | -16M -1.27B | EV / Sales 2015 | 1.07 x |
Net cash position 2015 | 13.54M 1.08B | Net cash position 2016 | 2.45M 195M | EV / Sales 2016 | 0.73 x |
P/E ratio 2015 |
-1.07
x | P/E ratio 2016 |
-0.54
x | Employees | 86 |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
1 day | +9,900.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 23/05/12 |
Nicole Massoll
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 21/12/09 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 592 | |
+24.69% | 44.96B | |
+1.47% | 42.65B | |
+45.66% | 41.85B | |
-4.27% | 29.04B | |
+11.52% | 26.08B | |
-20.30% | 19.03B | |
+6.60% | 12.75B | |
+28.75% | 12.06B | |
-3.75% | 11.75B |
- Stock Market
- Equities
- ROSGQ Stock